These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16998483)

  • 1. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells.
    Krause DS; Lazarides K; von Andrian UH; Van Etten RA
    Nat Med; 2006 Oct; 12(10):1175-80. PubMed ID: 16998483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche.
    Krause DS; Lazarides K; Lewis JB; von Andrian UH; Van Etten RA
    Blood; 2014 Feb; 123(9):1361-71. PubMed ID: 24394666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice.
    Pelletier SD; Hong DS; Hu Y; Liu Y; Li S
    Blood; 2004 Oct; 104(7):2163-71. PubMed ID: 15213099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBL-B is required for leukemogenesis mediated by BCR-ABL through negative regulation of bone marrow homing.
    Badger-Brown KM; Gillis LC; Bailey ML; Penninger JM; Barber DL
    Leukemia; 2013 Apr; 27(5):1146-54. PubMed ID: 23160449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
    Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells.
    Mumprecht S; Claus C; Schürch C; Pavelic V; Matter MS; Ochsenbein AF
    Blood; 2009 May; 113(19):4681-9. PubMed ID: 19252140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
    Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
    Chu S; McDonald T; Bhatia R
    Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.
    Lidonnici MR; Corradini F; Waldron T; Bender TP; Calabretta B
    Blood; 2008 May; 111(9):4771-9. PubMed ID: 18227349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
    Gross AW; Ren R
    Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
    Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
    J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model.
    Melkus M; Bennaceur-Griscelli A; Valogne Y; Flamant S; Chomel JC; Sorel N; Bonnet ML; Deininger MW; Mitjavila-Garcia MT; Turhan AG
    Exp Hematol; 2013 Apr; 41(4):335-45.e3. PubMed ID: 23287417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia.
    Jiang X; Stuible M; Chalandon Y; Li A; Chan WY; Eisterer W; Krystal G; Eaves A; Eaves C
    Blood; 2003 Oct; 102(8):2976-84. PubMed ID: 12829595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells.
    Zhou LL; Zhao Y; Ringrose A; DeGeer D; Kennah E; Lin AE; Sheng G; Li XJ; Turhan A; Jiang X
    J Exp Med; 2008 Oct; 205(11):2657-71. PubMed ID: 18936234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice.
    Peters DG; Klucher KM; Perlingeiro RC; Dessain SK; Koh EY; Daley GQ
    Oncogene; 2001 May; 20(21):2636-46. PubMed ID: 11420675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL.
    Chalandon Y; Jiang X; Loutet S; Eaves AC; Eaves CJ
    Leukemia; 2004 May; 18(5):1006-12. PubMed ID: 15014528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.
    Ramaraj P; Singh H; Niu N; Chu S; Holtz M; Yee JK; Bhatia R
    Cancer Res; 2004 Aug; 64(15):5322-31. PubMed ID: 15289338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of retroviral transduction in chronic myelogenous leukemia.
    Claxton D; Suh SP; Filaccio M; Ellerson D; Gaozza E; Andersson B; Brenner M; Reading C; Feinberg A; Moen R
    Hum Gene Ther; 1991; 2(4):317-21. PubMed ID: 1665348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia.
    Chu S; Li L; Singh H; Bhatia R
    Cancer Res; 2007 Jul; 67(14):7045-53. PubMed ID: 17638918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.